R
Ronald E. Ferrando
Researcher at Genentech
Publications - 30
Citations - 4644
Ronald E. Ferrando is an academic researcher from Genentech. The author has contributed to research in topics: Cancer & Beta (finance). The author has an hindex of 23, co-authored 30 publications receiving 4305 citations. Previous affiliations of Ronald E. Ferrando include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart,XiaoDong Huang,Jennie R. Lill,Jinfeng Liu,Ronald E. Ferrando,Dorothy French,Heather Maecker,Karen O'Rourke,Fernando Bazan,Jeffrey Eastham-Anderson,Peng Yue,David Dornan,David C.S. Huang,Vishva M. Dixit +13 more
TL;DR: The results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Journal ArticleDOI
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Kim Newton,Marissa L. Matsumoto,Ingrid E. Wertz,Donald S. Kirkpatrick,Jennie R. Lill,Jenille Tan,Debra L. Dugger,Nathaniel C. Gordon,Sachdev S. Sidhu,Frederic A. Fellouse,László G. Kömüves,Dorothy French,Ronald E. Ferrando,Cynthia Lam,Deanne M. Compaan,Christine Yu,Ivan Bosanac,Sarah G. Hymowitz,Robert F. Kelley,Vishva M. Dixit +19 more
TL;DR: This work has developed linkage-specific antibodies that recognize polyubiquitin chains joined through lysine 63 (K63) or 48 (K48) and uses these antibodies to demonstrate that RIP1, which is essential for tumor necrosis factor-induced NF-kappaB activation, and IRAK1, who participates in signaling by interleukin-1beta and Toll-like receptors, both undergo polyubiquein editing in stimulated cells.
Journal ArticleDOI
Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
Kim Newton,Debra L. Dugger,Katherine E. Wickliffe,Neeraj Kapoor,M. Cristina de Almagro,Domagoj Vucic,László G. Kömüves,Ronald E. Ferrando,Dorothy French,Joshua D. Webster,Merone Roose-Girma,Søren Warming,Vishva M. Dixit +12 more
TL;DR: The data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.
Journal ArticleDOI
Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.
Prescott G. Woodruff,Gregory Dolganov,Ronald E. Ferrando,Samantha Donnelly,Steven R. Hays,Owen D. Solberg,Roderick Carter,Hofer Wong,Peggy S. Cadbury,John V. Fahy +9 more
TL;DR: It is concluded that airway smooth muscle proliferation is a pathologic characteristic of subjects with mild to moderate asthma, however, smooth muscle cells in mild tomoderate asthma do not show hypertrophy or gene expression changes of a hypercontractile phenotype observed in vitro.
Journal ArticleDOI
Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
Julie Di Paolo,Tao Huang,Mercedesz Balazs,James Barbosa,James Barbosa,Kai H. Barck,Brandon J. Bravo,Richard A.D. Carano,James W. Darrow,Douglas R. Davies,Laura DeForge,Lauri Diehl,Ronald E. Ferrando,Steven L. Gallion,Anthony M. Giannetti,Peter Gribling,Vincent Hurez,Vincent Hurez,Sarah G. Hymowitz,Randall Mark Jones,Kropf Jeffrey E,Wyne P. Lee,Patricia Maciejewski,Scott A. Mitchell,Hong Rong,Bart L. Staker,J. Andrew Whitney,Sherry Yeh,Wendy B. Young,Christine Yu,Juan Zhang,Karin Reif,Kevin S. Currie +32 more
TL;DR: CGI1746 is described, a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation that decreases cytokine levels within joints and ameliorates disease.